New pill targets tough cancers with BRCA gene flaws

NCT ID NCT07356453

First seen Jan 28, 2026 · Last updated May 14, 2026 · Updated 11 times

Summary

This early-phase study tests a new drug called FORX-428 in people with advanced solid tumors that have BRCA1/2 mutations or other DNA repair problems. The main goals are to find a safe dose and check for side effects. About 40 adults whose cancer has worsened after standard treatment will take the drug, and researchers will also watch for any tumor shrinkage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Knight Cancer Institute

    RECRUITING

    Portland, Oregon, 97239, United States

    Contact Phone: •••-•••-••••

  • NEXT - Virginia Cancer Specialists

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact Phone: •••-•••-••••

  • START - Midwest

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

    Contact Phone: •••-•••-••••

  • START - San Antonio

    RECRUITING

    San Antonio, Texas, 78229, United States

    Contact Phone: •••-•••-••••

  • Stanford University Medical Center

    RECRUITING

    Palo Alto, California, 94304, United States

    Contact Phone: •••-•••-••••

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Phone: •••-•••-••••

  • University of Texas - MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-••••

  • Washington University St. Louis

    RECRUITING

    St Louis, Missouri, 63108, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.